Literature DB >> 9262939

Prevalence of antithyroid antibodies in mood disorders.

J J Haggerty1, S G Silva, M Marquardt, G A Mason, H Y Chang, D L Evans, R N Golden, C Pedersen.   

Abstract

We examined the prevalence of antimicrosomal and antithyroglobulin antibodies in psychiatric inpatients with unipolar depression (N = 218), bipolar disorder manic (N = 51), bipolar disorder depressed (N = 19), and bipolar disorder mixed (N = 26) in comparison with two control groups: psychiatric inpatients with adjustment disorder (N = 80) and family medicine outpatients without current psychiatric illness (N = 144). A statistical analysis that controlled for age and sex revealed the frequency of positive antibody titers not to be increased in patients with a diagnosis of unipolar depression (6.9%) or bipolar disorder manic (3.9%), when compared with patients with adjustment disorder (2.5%) and non-psychiatric subjects (6.9%). There was a weak trend toward an increased prevalence of antithyroid antibodies in patients with bipolar disorder, mixed (19%) or depressed subtype (16%). The excess occurrence of antibodies in patients with either mixed or depressed bipolar disorder did not appear to be related to lithium exposure, which was similar in all bipolar subgroups. When the intervening influences of age and sex are taken into account, unipolar depression does not appear to be associated with an excessive rate of antithyroid antibodies; however thyroid autoimmunity may be weakly associated with subtypes of bipolar disorder in which depressive symptoms are prominent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9262939

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  13 in total

1.  Autoimmune diseases, bipolar disorder, and non-affective psychosis.

Authors:  William W Eaton; Marianne G Pedersen; Philip R Nielsen; Preben Bo Mortensen
Journal:  Bipolar Disord       Date:  2010-09       Impact factor: 6.744

2.  Long-term lithium treatment and thyroid antibodies: a controlled study.

Authors:  Christopher Baethge; Holger Blumentritt; Anne Berghöfer; Tom Bschor; Tasha Glenn; Mazda Adli; Peter Schlattmann; Michael Bauer; Reinhard Finke
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

3.  [Prevalence of thyroid disorders in patients diagnosed with depression].

Authors:  M J Muñoz-Cruzado Poce; A J García Navas; M L Moreno Gómez; R Garratón Juliá; A Marcelo Martínez; A J Madueño Caro
Journal:  Aten Primaria       Date:  2000 Jul-Aug       Impact factor: 1.137

Review 4.  Is thyroxine during lithium therapy necessary?

Authors:  J H Lazarus
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

5.  Bipolar limbic expression of auto-immune thyroid targets: thyroglobulin and thyroid-stimulating hormone receptor.

Authors:  Meleshni Naicker; Nathlee Abbai; Strinivasen Naidoo
Journal:  Metab Brain Dis       Date:  2019-06-13       Impact factor: 3.584

6.  Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder.

Authors:  Wanqiu Yang; Miao Qu; Rui Jiang; XiaoE Lang; Xiang-Yang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-18       Impact factor: 5.760

7.  Antithyroid antibody-linked symptoms in borderline personality disorder.

Authors:  Thomas D Geracioti; Mitchel A Kling; Robert M Post; Philip W Gold
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

8.  Thyroid functions and bipolar affective disorder.

Authors:  Subho Chakrabarti
Journal:  J Thyroid Res       Date:  2011-07-26

9.  Post partum depression and thyroid function.

Authors:  Farahnaz Keshavarzi; Katayoun Yazdchi; Mehrali Rahimi; Mansour Rezaei; Vahid Farnia; Omran Davarinejad; Nasrin Abdoli; Mahmood Jalili
Journal:  Iran J Psychiatry       Date:  2011

10.  Thyroid function in clinical subtypes of major depression: an exploratory study.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Philippos Grammaticos; George St Kaprinis; Per Bech
Journal:  BMC Psychiatry       Date:  2004-03-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.